Immunometabolic-Endocrine Crosstalk

Immunometabolic-Endocrine Crosstalk refers to the complex and dynamic interactions between the immune system, metabolic processes, and endocrine signaling pathways. This bidirectional communication integrates immune responses with metabolic regulation and hormonal control to maintain homeostasis and coordinate physiological adaptations to internal and external stimuli. It involves cellular and molecular signaling networks that modulate immune cell function, metabolic pathways, and endocrine gland activity, influencing a wide range of biological processes including inflammation, energy balance, glucose and lipid metabolism, and hormonal secretion.

Components of Immunometabolic-Endocrine Crosstalk

Immune System

The immune system participates actively in metabolic regulation and endocrine function through immune cells such as macrophages, T cells, B cells, and dendritic cells. These cells produce cytokines, chemokines, and other mediators that influence metabolic tissues and endocrine glands. Immune activation states can alter systemic and local metabolism, while metabolic status feeds back to modulate immune cell phenotype and function.

Metabolic Processes

Metabolic pathways, including glycolysis, oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism, are tightly linked to immune cell behavior and endocrine signaling. Metabolites themselves can act as signaling molecules that affect immune and endocrine responses. The metabolic state of tissues such as adipose tissue, liver, muscle, and pancreas is crucial for maintaining systemic energy homeostasis and hormonal balance.

Endocrine System

Endocrine glands such as the pancreas, thyroid, adrenal glands, and adipose tissue secrete hormones that regulate both metabolism and immune functions. Hormones like insulin, glucagon, cortisol, thyroid hormones, leptin, and adiponectin act on immune cells and metabolic tissues to coordinate responses to stress, infection, and nutrient availability.

Molecular Mechanisms Underlying Crosstalk

Cytokines and Hormones as Mediators

Cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interferons serve as immune-derived signals that can affect endocrine function and metabolic pathways. Conversely, hormones like insulin and cortisol modulate immune responses by altering cytokine production and immune cell metabolism.

Signaling Pathways

Key intracellular signaling cascades mediate immunometabolic-endocrine interactions, including:

• Nuclear factor kappa B (NF-κB) pathway, which links inflammation with metabolic regulation.
• AMP-activated protein kinase (AMPK), a sensor of cellular energy status that influences immune responses and hormone action.
• Mammalian target of rapamycin (mTOR), integrating nutrient signals with immune cell growth and function.
• Janus kinase/signal transducer and activator of transcription (JAK/STAT), mediating cytokine and hormone signaling.

Metabolites as Signaling Molecules

Metabolites such as glucose, free fatty acids, lactate, and amino acids influence immune cell function and endocrine secretion. For example, excess free fatty acids can trigger inflammatory responses in adipose tissue macrophages, contributing to insulin resistance.

Physiological and Pathophysiological Implications

Energy Homeostasis and Immune Function

Immunometabolic-endocrine crosstalk ensures that immune responses are supported by adequate energy supply while preventing excessive inflammation that can disrupt metabolic and hormonal balance. During infection or stress, hormonal adjustments (e.g., increased cortisol) modulate immune activity and metabolic substrate utilization.

Obesity and Metabolic Syndrome

In obesity, chronic low-grade inflammation arises from adipose tissue immune cells producing proinflammatory cytokines. This inflammatory milieu disrupts insulin signaling pathways, leading to insulin resistance and altered endocrine function. The crosstalk between adipocytes, immune cells, and endocrine factors underlies the pathogenesis of metabolic syndrome.

Autoimmune and Endocrine Disorders

Altered immunometabolic-endocrine interactions contribute to diseases such as type 1 diabetes, where autoimmune destruction of pancreatic β-cells occurs, and thyroid autoimmune diseases, where immune-mediated inflammation affects hormone production. Dysregulation can also affect adrenal function and systemic metabolism.

Aging and Immunometabolism

Aging is associated with changes in immune response (immunosenescence) and metabolic regulation that impact endocrine function. Chronic low-grade inflammation ("inflammaging") alters hormone secretion and metabolic homeostasis, influencing susceptibility to metabolic and immune-related diseases.

Therapeutic Perspectives and Research Directions

Targeting Inflammation to Improve Metabolic and Endocrine Health

Pharmacological interventions aiming to modulate inflammatory cytokines or immune cell activity have potential to restore metabolic and endocrine balance in conditions such as type 2 diabetes and obesity.

Hormonal Modulation of Immune Responses

Therapeutic manipulation of hormones like leptin, adiponectin, or glucocorticoids can influence immune function and metabolic outcomes, offering approaches for managing autoimmune and metabolic disorders.

Metabolic Reprogramming of Immune Cells

Understanding how immune cell metabolism affects their function opens avenues for therapies that reprogram immune cells by targeting key metabolic pathways (e.g., mTOR, AMPK) to treat chronic inflammatory and endocrine diseases.

Biomarkers and Personalized Medicine

Identifying biomarkers that reflect immunometabolic-endocrine interactions can improve disease diagnosis, prognosis, and individualized treatment strategies, emphasizing the integration of immune, metabolic, and hormonal profiles.

Summary of Key Interactions

This integrated framework highlights the essential nature of immunometabolic-endocrine crosstalk in maintaining physiological balance and its disruption in multiple chronic diseases, providing a foundation for innovative therapeutic strategies.